Arkolith/Insider Trading/COCP/Form 4

Frost Phillip MD Et Al

Director, 10% OwnerCocrystal Pharma, Inc. (COCP) · full profile →Form 4 · filed Dec 29, 2025
Net Buying
Open-Market Buys
$63K
Open-Market Sells
$0
Net Open-Market Flow
$63K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 26, 2025Buy(P)40K$0.97$39K1.8M
Dec 24, 2025Buy(P)25K$0.97$24K1.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-029257) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML